Burlington School District v. Monsanto Co.

District Court, D. Vermont·Decided June 11, 2024·No. 2:22-cv-00215·Unknown

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF VERMONT

BURLINGTON SCHOOL DISTRICT, ) ) Plaintiff, ) ) v. ) Case No. 2:22-cv-215 ) MONSANTO CO., SOLUTIA, INC., ) and PHARMACIA LLC, ) ) Defendants. )

OPINION AND ORDER

The Burlington School District (“BSD”) commenced this action after discovering polychlorinated biphenyls (“PCBs”) at Burlington High School. Defendants Monsanto Co., Solutia, Inc., and Pharmacia LLC (collectively “Monsanto”) are allegedly successors to the old Monsanto company, which was the primary manufacturer of PCBs in the United States for several decades, including when Burlington High School was built. The Complaint alleges that Monsanto failed to alert BSD to the dangers posed by the presence of PCBs in school buildings, testing revealed dangerous levels of PCBs on the school campus, and Defendants are now liable for the cost of razing and rebuilding the school. Pending before the Court is BSD’s motion to compel materials from seven arbitrations in which Monsanto litigated PCB-related issues with insurers and tort plaintiffs. BSD also moves to compel privilege logs for materials from two mediations. For the reasons set forth below, the motion to compel is granted in part and denied in part. Background

Monsanto has reportedly engaged in seven arbitrations and two mediations over the past 40 years regarding PCB liability. Two arbitrations took place in England in 2014 and 2017 between Monsanto and its insurers. Two other arbitrations occurred in California in 1984-85, again between Monsanto and its insurers. Three arbitrations took place in Missouri in 2015 between Monsanto and tort plaintiffs. Monsanto also mediated twice with tort plaintiffs in California in 2015. BSD has requested transcripts, sworn statements, exhibits, and discovery responses from those nine proceedings. Monsanto has not produced the documents, raising objections on grounds of relevance, confidentiality and/or privilege.

Discussion Under Federal Rule of Civil Procedure 26(b)(1), a party may seek any discovery “regarding any nonprivileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case.” When assessing proportionality, a court considers “the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit.” Fed. R. Civ. P. 26(b)(1). In the discovery phase of a case, the concept of relevance is “liberally construed.” Daval Steel Prods. v. M/V Fakredine, 951 F.2d 1357, 1367 (2d Cir. 1991) (citing Oppenheimer Fund, Inc. v. Sanders, 437 U.S. 340, 351

(1978)). I. Arbitration Materials A. Relevance Beginning with the arbitration-related documents, BSD submits that the documents are relevant insofar as they speak to the toxicity of PCBs and Monsanto’s knowledge of any such toxicity. Monsanto contends that such document production would be cumulative since those matters will be addressed in the context of BSD’s other discovery requests: “BSD does not demonstrate that the other documents it seeks contain

information that is relevant to the claims and defenses in this case, over and above the information that it will likely receive in response to other of its requests.” ECF No. 82 at 13. In a related argument, Monsanto submits that BSD has failed to show that it is unable to obtain the same information through other discovery. Monsanto cites no authority for the proposition that a party may not request discovery materials if those materials are “likely” to be produced in response to other requests. While the Court acknowledges the volume of production in this case, including Monsanto’s PCB Litigation Archive and its Archive Extension, BSD is entitled to seek documents from all sources so

long as its requests meet the requirements of Rule 26(b)(1). Monsanto also argues that BSD must meet a heightened relevancy standard given that the requested materials are confidential. The case upon which Monsanto primarily relies, In re Teligent, Inc., 640 F.3d 53 (2d Cir. 2011), addressed the confidentiality of settlement negotiations protected by a court order. As such, In re Teligent has been distinguished from a situation where, as in this case, parties entered into private agreements without a “prior court promise of confidentiality.” See Rocky Aspen Mgmt. 204 LLC v. Hanford Holdings LLC, 394 F. Supp. 3d 461, 463-65 (S.D.N.Y. 2019). Monsanto cites to no authority applying a heightened relevancy standard to private

arbitration proceedings. Even assuming both confidentiality and a heightened standard, however, the Court finds that BSD has established sufficient relevance. While Monsanto argues that the arbitration proceedings in other jurisdictions did not directly address the claims brought in this case, BSD is nonetheless entitled to access Monsanto’s documents to the extent they may relate to PCB toxicity and Monsanto’s awareness of such toxicity over time. B. Confidentiality Monsanto further objects to production on the basis of restrictions set forth in private confidentiality agreements

entered into in the context of the arbitrations. Monsanto again relies on the Second Circuit’s ruling in In re Teligent which, as discussed above, applied to court-ordered and court-protected mediation. 640 F.3d at 56-57, 62. Monsanto also cites Second Circuit precedent addressing the confidentiality of arbitration proceedings in the context of public access. See, e.g., Guyden v. Aetna, Inc., 544 F.3d 376, 385 (2d Cir. 2008) (rejecting whistleblower’s argument that she should be able to inform co- workers of her claim); Gambale v. Deutsche Bank AG, 377 F.3d 133, 143 (2d Cir. 2004) (protecting confidential settlement amount revealed in court transcript). Those cases are not controlling, as general public access is not the same as a party

seeking materials relevant to its litigation claims. The Court agrees with BSD that a confidentiality agreement entered into by settling parties does not, in and of itself, bind third parties. Specifically, the alleged confidentiality agreements do not bar a third party from accessing information in discovery. See, e.g., Gotham Holdings, LP v. Health Grades, Inc., 580 F.3d 664, 665 (7th Cir. 2009) (“No one can ‘agree’ with someone else that a stranger’s resort to discovery under the Federal Rules of Civil Procedure will be cut off.”); Giannaccio v. United States, No. 3:12CV609 (DJS), 2015 WL 13864988, at *3 (D. Conn. Mar. 3, 2015) (“The Court agrees that a confidentiality agreement entered into by settling parties

does not, in and of itself, bar discovery of the settlement agreement by one not a party to the settlement.”). Moreover, discovery in this case is governed by a protective order. As a result, any concerns about violating a confidentiality agreement may be assuaged by the existence of that order. To the extent the protective order needs to be modified, the parties may propose such modifications to the Court. C.

Free access — add to your briefcase to read the full text and ask questions with AI

Burlington School District v. Monsanto Co., (D. Vt. 2024).

Burlington School District v. Monsanto Co. (Burlington School District v. Monsanto Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Klaxon Co. v. Stentor Electric Manufacturing Co.
313 U.S. 487 (Supreme Court, 1941)
Oppenheimer Fund, Inc. v. Sanders
437 U.S. 340 (Supreme Court, 1978)
In Re Teligent, Inc.
640 F.3d 53 (Second Circuit, 2011)
Gotham Holdings, LP v. Health Grades, Inc.
580 F.3d 664 (Seventh Circuit, 2009)
Guyden v. Aetna, Inc.
544 F.3d 376 (Second Circuit, 2008)
Amiot v. Ames
693 A.2d 675 (Supreme Court of Vermont, 1997)
Equity Residential v. Kendall Risk Management, Inc.
246 F.R.D. 557 (N.D. Illinois, 2007)